Yoshiki Arakawa

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 719 citations · Full text

Medicine, Neurology, Oncology +8

ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts

Takahiro Tsuji, Toshimasa Ishizaki, Muneo Okamoto et al. · The Journal of Cell Biology · 2002 · 211 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neurons

Yoshiki Arakawa, Haruhiko Bito, Tomoyuki Furuyashiki et al. · The Journal of Cell Biology · 2003 · 203 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

The Rho-mDia1 Pathway Regulates Cell Polarity and Focal Adhesion Turnover in Migrating Cells through Mobilizing Apc and c-Src

Norikazu Yamana, Yoshiki Arakawa, Tomohiro Nishino et al. · Molecular and Cellular Biology · 2006 · 186 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma

Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima et al. · Neuro-Oncology · 2020 · 184 citations · Full text

Medicine, Oncology, Pharmacology +17